To assess the value of various methods for long-term followup of diabetic patients,
we compared the concentrations of fructosamine in serum with those of various glycated proteins: hemoglobin (HbA1 ), total serum proteins (G-prot), and albumin (G-alb), assayed in 30 pregnant insulin-dependent diabetics every two weeks after initial determination of a 24-h blood glucose profile. HbA1C Evidently the fructosamine assay is not an adequate alternative to HbA1C, G-alb, or G-prot as an index to long-term control of blood glucose in such patients. 
Materials and Methods

Patients
'P <0.001 (hIgher than controls). P <0.01 (higher than pregnant diabetics). #{176}P <0.05 (higher than pregnant diabetics). and HbAIC and fructosamine the worst. Figure  3 shows the change of the various glycated proteins with time in four individual pregnant IDD patients. In all four patients the change in fructosamine was much smaller than the change in results of the other three assays for glycated proteins, and often the change was opposite to that of the other assays ( Figure  3, b, c, and d) . The change in HbA1C was smaller ( Figure  3b ) and occurred later ( Figure  3d ) than that of G-prot and G-alb. This is compatible with the longer biological half-life of HbA1 . G-alb, G-prot, and HbA1 displayed the same change in most of the cases. We studied the concordance between an increase or decrease of the various assay results in 30 pregnant IDD patients.
The changes in G-alb and G-prot between consecutive samples were concordant in 55 of 65 cases (85%), but the change in fructosamine was concordant with G-alb and G-prot in only 38 of 68 (56%) and 37 of 67 samples (55%), respectively. 
Discussion
Assays
